Kpɔkplɔyiɖeme
Retatrutid , si nye atike yeye aɖe si me wozãa atike etɔ̃ le si ŋu wole numekuku wɔm le fifia le atikewɔƒewo, le amewo ƒe ɖetsɔleme gã aɖe hem vɛ le ŋutete si le esi be wòatrɔ asi le kpekpeme dzi kpɔkpɔ kple lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe atikewɔwɔ ƒomevi 2 lia ŋu. Dɔnɔwo, lãmesẽdɔwɔlawo, kple ɖoɖowɔlawo katã le nya vevi ɖeka ma ke biam: Ga home nenie Retatrutid axɔ ne enya ɖo asi me ko? Gazazã ƒe tɔtrɔ, nugblẽfexeɖoɖo, kple kuxi siwo le alesi woate ŋu akpɔe ŋu gɔmesese le vevie ŋutɔ, elabena ga si woate ŋu aƒlee afia nenye be atike sia ava zu nusi woate ŋu akpɔ le afisiafi alo wòagakpɔtɔ anye nusi gbɔ dɔnɔ akpa gãtɔ mate ŋu akpɔ o. Nyati sia ku Retatrutid ƒe asixɔxɔ si wokpɔ mɔ na, nugblẽfexeɖoɖo ƒe mɔxenuwo, kple nusiwo wògblẽna le lãmesẽnyawo gbɔ kpɔkpɔ ƒe mɔnukpɔkpɔ si keke ta wu ŋu.
Retatrutid ƒe Asixɔxɔ Si Wokpɔ Mɔ Na
Togbɔ be Retatrutid mexɔ FDA ƒe mɔɖeɖe haɖe o hã la, akɔntabubu gbãtɔwo ɖee fia be ate ŋu azɔ ɖe asixɔxɔ ƒe mɔzɔzɔ si le GLP-1 receptor agonists bubu siwo to vovo abe semaglutide (Ozempic, Wegovy) kple tirzepatide (Mounjaro, Zepbound) ene ŋu dzi. Zi geɖe la, atike siawo xɔa dɔlar 1,000–1,400 ɣleti sia ɣleti le United States nugblẽfexeɖoɖo manɔmee. Ne míebu Retatrutid ƒe dɔwɔwɔ etɔ̃ ƒe mɔnu kple viɖe siwo ate ŋu anɔ eŋu le eƒe dɔwɔwɔ me ta la, ate ŋu adze egɔme le asi ma tɔgbe alo esi lolo wu gɔ̃ hã dzi. Zi geɖe la, atikewɔƒewo nɔa te ɖe numekuku kple ŋgɔyiyi ƒe gadede asi, asitsatsa ƒe didi si wokpɔ mɔ na, kple hoʋiʋli ƒe nɔnɔme dzi ɖoa ŋgɔdonya ƒe asiwo. Abe alesi wòle le atike bubu siwo wozãna tsɔ ɖea lolo dzi kpɔtɔna gome ene la, gazazã ate ŋu ato vovo ŋutɔ le agbɔsɔsɔ kple alesi wowɔe nu.
Ɣleti sia Ɣleti ƒe Asixɔxɔ si Wobu be Woaɖo
| Atikewo |
ƒe Ɣleti sia Ɣleti ƒe Gazazã (U.S.) |
Mɔnu |
| Semaglutid (Ozempic/Wegovy ƒe lã) . |
Dɔlar 1,000–dɔlar 1,300 |
GLP-1 ƒe atike si nye agonist |
| Tirzepatid (Mounjaro/Zepbound) ƒe ʋuƒoƒo . |
Dɔlar 1,000–dɔlar 1,400 |
GLP-1/GIP ƒe atike eve |
| Retatrutid (wole mɔ kpɔm na) . |
Dɔlar 1,200–dɔlar 1,600 |
GLP-1/GIP/Glucagon ƒe atike etɔ̃ |
Nusiwo Kpɔa Ŋusẽ Ðe Retatrutid ƒe Gazazã Dzi
Ga homewo ƒe asixɔxɔ manɔ anyi le teƒe si me naneke mele o. Nu geɖe siwo trɔna la trɔa asi le Retatrutid ƒe gazazã mlɔeba ŋu:
Numekuku Kple Ŋgɔyiyi ƒe Gazazãwo – Atikewɔƒewo dea ga biliɔn geɖe ɖe dɔdamɔnu dodokpɔwo, wo wɔwɔ, kple ɖoɖowɔwɔ ƒe ɖoɖowo me. Anɔ eme be Retatrutid ƒe mɔnu deŋgɔ si nye triple-agonist la abia be woadoe kpɔ geɖe wu, si kpɔ ŋusẽ ɖe eƒe asi mamlɛtɔ dzi.
Asi Hoʋiʋli – Esi Wegovy, Mounjaro, kple atike bubu siwo wozãna le pɔmpi me li ta la, hoʋiʋli ƒe nyaƒoɖeamenu ate ŋu axe mɔ ɖe asixɔxɔ si gbɔ eme nu. Gake nudidi geɖe kple nusiwo woana ƒe ʋɛ ate ŋu ana gazazãwo nadzi ɖe edzi.
Adzɔnuwo wɔwɔ ƒe Sesẽ – Atike siwo me nugbagbeviwo le abe Retatrutid ene wɔwɔ xɔ asi, ebia dɔwɔƒe tɔxɛwo kple woƒe nyonyome dzi kpɔkpɔ vevie.
Sedede kple Ðoɖowɔɖi ƒe Nɔnɔme – United States ƒe atikewo ƒe asixɔxɔ mekpɔa dziɖuɖu ƒe sedede o ne wotsɔe sɔ kple dukɔ bubuwo, si fia be Amerika dɔnɔwo ateŋu adze ŋgɔ gazazã siwo lolo wu esiwo le Europa alo Canada.
Nugblẽfexeɖoɖo ƒe Nugblẽfexeɖoɖo na Retatrutid
Nugblẽfexeɖoɖo awɔ akpa vevi aɖe le alesi woate ŋu akpɔe me. Nusiwo le edzi yim fifia ɖee fia be nugblẽfexeha geɖe siwo dzraa nugblẽfexeɖoɖowo xea mɔ ɖe nugblẽfexeɖoɖo si woaxe ɖe atike siwo tsia lolo akpa nu ta nu alo ɖea wo ɖa, ne wona nugblẽfexeɖoɖo na lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe atikewɔwɔ gɔ̃ hã. Le kpɔɖeŋu me, se xe mɔ na Medicare be wòagaxe fe ɖe atike siwo wozãna tsɔ ɖea lolo dzi kpɔtɔna ta o, togbɔ be sedede ƒe agbagbadzedzewo le edzi yim be woatrɔ ɖoɖo sia hã. Ne Retatrutid xɔ mɔɖeɖe ɖe lãmenugbagbeviwo ƒe dɔwɔwɔ kple lolo akpa siaa ŋu la, ga si woaxe ɖe eta ate ŋu ato vovo le atikewɔwɔ ƒe dzesi nu.
Nugblẽfexeɖoɖo ƒe Nɔnɔme Siwo Ate Ŋu Adzɔ:
| Nɔnɔme si me wòle |
Nusiwo Ate Ŋu Adzɔ be Woatsɔ Axe Dɔa |
Ŋusẽkpɔɖeamedzi ɖe Dɔnɔwo Dzi |
| Retatrutid si dzi woda asi ɖo na lãmenugbagbeviwo ƒe dɔwɔwɔ ɖeɖeko |
Kɔ |
Woxea fe na suklidɔlélawo; woɖee ɖa le lolo akpa ta |
| Woda asi ɖe edzi na lolo akpa ɖeɖeko |
Nusiwo le bɔbɔe–siwo le titina |
Nugblẽfexeha ƒe vixɔxɔnyi si seɖoƒe li na; kotoku me gazazã siwo lolo wu |
| Woda asi ɖe edzi na nɔnɔme eveawo siaa |
Le ve dome |
Nusiwo keke ta wu gake mɔxeɖenuwo le eŋu (afɔɖeɖe ƒe atikewɔwɔ, mɔɖeɖe do ŋgɔ) . |
Mɔnukpɔkpɔ ƒe Kuxiwo le United States ƒe Asi me
Le nugblẽfexeɖoɖo gɔ̃ hã gome la, wokpɔa mɔ be kuxiwo nado mo ɖa le nugblẽfexeɖoɖo me. Dɔnɔwo ate ŋu adze ŋgɔ fetu gbogbo aɖewo siwo woaxe ɖekae, woabia mɔɖeɖe do ŋgɔ, kple ƒe sia ƒe ƒe seɖoƒewo na atike siwo wozãna tsɔ ɖea lolo dzi kpɔtɔna. Anɔ eme be woaɖe asi le dɔnɔ siwo ƒe fetu mede o siwo si nugblẽfexeɖoɖo blibo mele o ŋu, si ana woatsi dzi ɖe lãmesẽnyawo ƒe sɔsɔ ŋu. Tsɔ kpe ɖe eŋu la, wogblɔ be GLP-1 atikewo ƒe veve xoxo, si na wòte ŋu dzɔ be Retatrutid ate ŋu adze ŋgɔ nuzazãwo ƒe kɔsɔkɔsɔ ƒe nya mawo tɔgbe le eƒe dodo me.
Mɔxenuwo ate ŋu anye:
Woxea fe ɖe lolo akpa ɖeɖeko ƒe atikewɔwɔ ta
Anyigba ƒe vovototo le nugblẽfexeɖoɖo ƒe anyinɔnɔ me
Ŋusẽkpɔɖeamedzi si mesɔ o ɖe ameha siwo woɖe ɖe aga dzi
Mɔnukpɔkpɔ le U.S. Godo
Atikewo ƒe asi kple woƒe asixɔxɔ to vovo ŋutɔ le dukɔ vovovowo me. Le asi siwo me dziɖuɖu ƒe nudzraɖoɖo ƒe ŋusẽ sẽŋu le, abe Canada, Germany, alo UK ene me la, anɔ eme be woatsɔ Retatrutid ana le asi si dzi woɖe kpɔtɔ ŋutɔ ne wotsɔe sɔ kple United States tɔ. Gake eƒe anyinɔnɔ ate ŋu atsi megbe le United States ƒe mɔɖeɖe te le nutome ƒe ɖoɖowo ƒe ɣeyiɣiɖoɖowo ta. Le dɔnɔ siwo le dukɔ madeŋgɔwo me gome la, mɔxexe ɖe woƒe mɔnukpɔkpɔwo nu asẽ wu, si ana woabia nya tso xexeame katã ƒe lãmesẽnyawo ƒe sɔsɔ ŋu.
Xexeame Katã ƒe Atikewo ƒe Asixɔxɔ ƒe Kpɔɖeŋuwo Tsɔtsɔ Sɔ Kple Wo Nɔewo
| Nuto |
Atikewo ƒe Asixɔxɔ Ŋuti Mɔnu Si Wozãna |
Anɔ eme be Ŋusẽkpɔɖeamedzi Ðe Retatrutid Dzi |
| MÍ |
Asi-ʋuʋu, ɖoɖowɔwɔ suetɔ kekeake |
Ga home kɔkɔtɔwo kekeake, asixɔxɔ si seɖoƒe li na |
| Europa (Germany, Eŋlisiawo) . |
Asixɔxɔ ŋuti nyamedzroƒe, lãmesẽnyawo ŋuti mɔ̃ɖaŋununya ƒe dodokpɔ |
Ga home siwo bɔbɔ ɖe anyi, wohe ɖe megbe le wo zazã me |
| Canada |
Dukɔa ƒe atikewo ƒe asi ŋuti sedede |
Ga home siwo bɔbɔ ɖe anyi le mɔ si sɔ nu |
| Dukɔ madeŋgɔwo |
Nuƒleŋutete si seɖoƒe li na, ŋuɖoɖo ɖe atike siwo wozãna ɖaa ŋu |
Woxe mɔ ɖe amewo ƒe gege ɖe eme nu vevie |
Dɔnɔwo Kpekpeɖeŋunaɖoɖowo Kple Mɔnu Bubuwo
Ne Retatrutid ƒe asi sɔ kple Wegovy alo Mounjaro tɔ la, adzɔnuwo wɔlawo ate ŋu ana kpekpeɖeŋunana dɔnɔwo ƒe ɖoɖowo, fexexe ɖekae ƒe agbalẽviwo, alo gadzadzraɖo ƒe ɖoɖowo be woaɖe gazazãwo dzi akpɔtɔ na dɔnɔ siwo dze. Gake zi geɖe la, ɖoɖo siawo ɖea Medicare kple Medicaid ƒe viɖekpɔlawo ɖa, si wɔnɛ be womete ŋu ɖoa wo gbɔ o. Dɔnɔwo ate ŋu abu mɔnu bubuwo hã ŋu, abe:
Trɔtrɔ ɖe GLP-1 agonists bubu siwo ƒe dɔwɔwɔ keke ta wu ŋu
Dɔdamɔnu dodokpɔwo ƒe ŋkɔ ŋɔŋlɔ me dzodzro be woakpɔe kaba
Ne míebu atike siwo wotsɔ ƒo ƒui ŋu (togbɔ be dedienɔnɔ kple senyawo ŋue wotsi dzi ɖo hã) .
Ɣeyiɣi Didi ƒe Asixɔxɔ Ŋuti Mɔkpɔkpɔ
Le ɣeyiɣi aɖe megbe la, Retatrutid ƒe asi ate ŋu aɖiɖi le esi:
Asitsatsa ƒe hoʋiʋli tso dzidzime si gbɔna ƒe atikewɔwɔwo gbɔ
Generic alo biosimilar versions (togbɔ be esia ate ŋu axɔ ƒe 10–15 le mɔɖeɖe ɖe eŋu megbe hã)
Ðɔɖɔɖo siwo wowɔ le ɖoɖowo me le atikewo ƒe asixɔxɔ kple nugblẽfexeɖoɖowo me
Woakeke dɔa ɖe enu ne wole lolo akpa kpɔm dze sii geɖe wu be enye dɔléle si nɔa anyi didi si hiã be woakpɔ egbɔ ɣeyiɣi didi
Ke hã, le ɣeyiɣi kpui aɖe me la, ele be dɔnɔwo nakpɔ mɔ be asixɔxɔ si sɔ kple Wegovy kple Mounjaro alo lolo wu, eye nugblẽfexeɖoɖowo kple dɔnɔwo ƒe kpekpeɖeŋunaɖoɖowo dzie woƒe asixɔxɔ anɔ te ɖo.
Nyanuwuwuw
Retatrutid tsi tre ɖi na atike si ate ŋu atrɔ asi le lolo akpa kple lãmenugbagbeviwo ƒe dɔwɔwɔ ƒomevi eve ŋu, gake anɔ eme be eƒe gazazã anye nusi aɖe ŋusẽ si wòakpɔ ɖe ame dzi ŋutɔŋutɔ le xexeame. Esi wobu akɔnta be woƒe asi anɔ dɔlar 1,200–1,600 ɣleti sia ɣleti ta la , kuxi siwo le alesi woate ŋu akpɔe ŋu godoo, vevietɔ le United States afisi nugblẽfexeɖoɖo si wowɔna na lolo akpa ƒe atikewo gakpɔtɔ mewɔ ɖeka o. Togbɔ be kpekpeɖeŋunana dɔnɔwo ƒe ɖoɖowo ate ŋu ana gbɔdzɔe aɖewo hã la, mɔxenu siwo le ɖoɖo nu abe mɔxexe ɖe nugblẽfexeɖoɖowo nu, nugblẽfexeɖoɖowo ƒe vovototodedeameme, kple asixɔxɔ ƒe vovototo le xexeame katãe atrɔ asi le eƒe asiɖoɖoanyi ŋu. Be Retatrutid nawɔ eƒe ŋugbedodoa dzi la, ele be nugblẽfexehawo, nugblẽfexehawo, kple adzɔnuwo wɔlawo nakpɔ gazazã kple ga si woatsɔ awɔ dɔe ƒe dzitsitsiwo gbɔ ŋkume kple ŋkume.
Nyabiasewo ƒe Nyabiasewo
1. Ga home nenie Retatrutid axɔ?
Akɔntabubu gbãtɔwo ɖee fia be dɔlar 1,200–1,600 ɣleti sia ɣleti le U.S., si sɔ kple Wegovy kple Mounjaro alo lolo wu.
2. Ðe nugblẽfexeɖoɖo axe fe ɖe Retatrutid ta?
Anɔ eme be alesi woaxe fe ɖe eta anɔ te ɖe nenye be woda asi ɖe edzi na lãmenugbagbeviwo ƒe dɔwɔwɔ, lolo akpa, alo evea siaa dzi. Nugblẽfexeha geɖe xea mɔ ɖe nugblẽfexexe ɖe atike siwo wozãna tsɔ ɖea lolo dzi kpɔtɔna ta.
3. Ðe Medicare axe fe ɖe Retatrutid ta?
Fifia la, wode se na Medicare be wòagaxe fe ɖe atike siwo wozãna tsɔ ɖea lolo dzi kpɔtɔna ta o. Ahiã be woawɔ tɔtrɔ le sewo me hafi woate ŋu ade eme.
4. Ðe Retatrutid ƒe asi abɔbɔ wu le U.S. godoa?
Ɛ̃. Zi geɖe la, dukɔ siwo me dziɖuɖua dzroa asixɔxɔwo me le la kpɔa asi siwo bɔbɔ ɖe anyi, gake wo zazã ate ŋu anɔ blewu.
5. Ðe mɔnu bubu aɖewo li siwo ƒe asi bɔbɔ wu ɖe Retatrutid teƒea?
GLP-1 atike bubuwo abe semaglutide alo tirzepatide ene ate ŋu ana viɖe mawo tɔgbe, gake asixɔxɔ gakpɔtɔ le gã le atikeawo katã me.
